Você procurou por: immunogenicity (Francês - Inglês)

influence of helical organization on immunogenicity and antigenicity of synthetic peptides.
influence of helical organization on immunogenicity and antigenicity of synthetic peptides.

immunogenicity of acellular pertussis vaccines using two vaccines for primary immunization.
immuno- genicity of acellular pertussis vaccines using two vaccines for primary immunization.

comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia.
comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia.

safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.
safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.

conjugate meningococcal serogroup a and c vaccine: reacto genicity and immunogenicity in united kingdom infants.
immune response of human infants of polysaccharide vaccines of group a and c neisseria meningitidis.

reactogenicity and immunogenicity in mother and infant. j infect dis 1979;140:141-46.
reactogenicity and immunogenicity in mother and infant . j infect dis 1979;140:141-46.

safety, immunogenicity, and induction of immunologic memory by a serogroup c meningococcal conjugate vaccine in infants:
safety, immunogenicity, and induction of immunologic memory by a serogroup c meningococ- cal conjugate vaccine in infants:

primary structure of the membrane and nucleocapsid protein gènes of féline infectious peritonitis virus and immunogenicity of recombinant vaccinia viruses in kittens.
primary structure of the membrane and nucleocapsid protein genes of feline infectious peritonitis virus and immunogenicity of recombinant vaccinia viruses in kittens.

immunogenicity and protective efficacy in the siv macaque model power, christopher - university of calgary university of calgary neurotoxic mechanisms mediated by lentivirusinduced proteolysis
immunogenicity and protective efficacy in the siv macaque model power, christopher - university of calgary hollenberg, morley d / overall, christopher m university of calgary neurotoxic mechanisms mediated by lentivirusinduced proteolysis

a randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group c conjugate vac cine in young british infants.
a randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group c conjugate vaccine in young british infants.

safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 l1 virus-like particle vaccine in preadolescents and adolescents.
cervical cancer and use of hormonal contraceptives: a systematic review. lancet.

granoff dm, morgan a, welsch j. immunogenicity of an investigational quadrivalent neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old children.
granoff dm, morgan a, welsch j. immunogenicity of an investigational quadrivalent neisseria meningitidis-diph-theria toxoid conjugate vaccine in 2-year old children.

safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen- month- old infants.
safety and immuno- genicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen- month-old infants.

comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis b, inactivated polio (dtpa-hbv-ipv) vaccine, mixed with the haemophilus influenzae type b (hib) conjugate vaccine and administered as a single injection, with the dtpa-ipv/hib and hepatitis b vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age.
comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis b, inactivated polio (dtpa-hbv- ipv) vaccine, mixed with the haemophilus influenzae type b (hib) conjugate vaccine and administered as a single injection, with the dtpa-ipv/hib and hepatitis b vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age.